Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5097-5104

  Thompson, Todd A ^a,c   Kim, Kwanghee ^a   Gould, Michael N ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE ACTIVATION; GENE FREQUENCY; GENE SEQUENCE; HISTOPATHOLOGY; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS;

ANIMALS; DEFECTIVE VIRUSES; FEMALE; GENE EXPRESSION REGULATION; GENES, RAS; GENETIC VECTORS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM PROTEINS; PREGNANCY; RAS PROTEINS; RATS; RNA, MESSENGER; TRANSFECTION;

EID: 0032533861     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
2. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
3. Balmain, A., and Brown, K. Oncogene activation in chemical carcinogenesis. Adv. Cancer Res., 51: 147-182, 1988.
4. Sukumar, S., Notario, V., Martin-Zanca, D., and Barbacid, M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature (Lond.), 306: 658-661, 1983.
5. Zhang, R., Haag, J. D., and Gould, M. N. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res., 50: 4286-4290, 1990.
6. Zhang, R., Haag, J. D., and Gould, M. N. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland. Cell Growth Differ., 2: 1-6, 1991.
7. Jacoby, R. F., Alexander, R. J., Raicht, R. F., and Brasitus, T. A. K-ras mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis (Lond.), 13: 45-49, 1992.
8. Visvanathan, K. V., Pocock, R. D., and Summerhayes, I. C. Preferential and novel activation of H-ras in human bladder cancer. Oncogene Res., 3: 77-86, 1988.
9. Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-de Vries, M., van Boom, J. H., van der Eb, A. J., and Vogelstein, B. Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
10. Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., and Perucho, M. Detection of high incidence of K-ras oncogenes during human colon carcinogenesis. Nature (Lond.), 327: 298-303, 1987.
11. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
12. Bos, J. L., Verlaan-de Vries, M., van der Eb, A. J., Janssen, J. W. G., Delwel, R., Lowenberg, B., and Colly, L. P. Mutations in N-ras predominate in acute myeloid leukemia. Blood, 69: 1237-1241, 1987.
13. Leon, J., Guerrero, I., and Pellicer, A. Differential expression of the ras gene family in mice. Mol. Cell. Biol., 7: 1535-1540, 1987.
14. Nieto, A., Qasba, P. K., Nakhasi, H. L., and Dhar, R. Differential regulation of c-Ha-ras and c-Ki-ras gene expression in rat mammary gland. Carcinogenesis (Lond.), 8: 1955-1958, 1987.
15. Guerrero, I., and Pellicer, A. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat. Res., 185: 293-308, 1987.
16. James, G. L., Goldstein, J. L., and Brown, M. S. Polylysine, and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J. Biol. Chem., 270: 6221-6226, 1995.
17. Zhang, F. L., Kirschmeier, P., Carr, D., James, L., Bond, R. W., Wang, L., Patton, R., Windsor, W. T., Syto, R., Zhang, R., and Bishop, W. R. Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J. Biol. Chem., 15: 10232-10239, 1997.
18. Umanoff, H., Edelmann, W., Pellicer, A., and Kucherlapati, R. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. USA, 92: 1709-1713, 1995.
19. Johnson, L., Greenbaum, D., Cichowski, K., Mercer, K., Murphy, E., Schmitt, E., Bronson, R. T., Umanoff, H., Edelmann, W., Kucherlapati, R., and Jacks, T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev., 11: 2468-2481, 1997.
20. Gould, M. N. Rodent models for the study of etiology, prevention, and treatment of breast cancer. Semin. Cancer Biol., 6: 147-152, 1995.
21. Wang, B., Kennan, W. S., Yasukawa-Barnes, J., Linstrom, M. J., and Gould, M. N. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors. Cancer Res., 51: 2642-2648, 1991.
22. Shimizu, K., Birnbaum, D., Ruley, M. A., Fasano, O., Suard, Y., Edlund, L., Taparowsky, E., Goldfarb, M., and Wigler, M. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature (Lond.), 304: 497-513, 1983.
23. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. New York: Cold Spring Harbor Laboratory Press, 1989.
24. Danos, O., and Mulligan, R. C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA, 85: 6460-6464, 1988.
25. Miller, A. D., and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6: 2895-2902, 1986.
26. Kriegler, M. Gene Transfer and Expression, A Laboratory Manual. New York: Stockton Press, 1990.
27. Miller, A. D., Trauber, D. R., and Buttimore, C. Factors involved in production of helper virus-free retrovirus vectors. Somat. Cell Mol. Genet., 12: 175-183, 1986.
28. Galang, C. K., Der, C. J., and Hauser, C. A. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene, 9: 2913-2921, 1994.
29. Nakazawa, H., Aguelon, A-M., and Yamasaki, H. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Oncogene, 7: 2295-2301, 1992.
30. Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., and Barbacid, M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature (Lond.), 315: 382-385, 1985.
31. Carbone, A., Gusella, G. L., Radzioch, D., and Varesio, L. Human Harvey-ras is biochemically different from Kirsten-or N-ras. Oncogene, 6: 731-737, 1991.
32. Maher, J., Baker, D. A., Manning, M., Dibb, N. J., and Roberts, I. A. G. Evidence for cell-specific differences in transformation by N-, H-, and K-ras. Oncogene, 11: 1639-1647, 1995.
33. Yan, Z., Chen, M-X., Perucho, M., and Friedman, E. Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin β1-chain maturation in colon epithelial cells. J. Biol. Chem., 272: 30928-30936, 1997.
34. Lu, S-J., Laroye, G., and Archer, M. C. Mammary tumor induction by N-methyl-N-nitrosourea in genetically resistant Copenhagen rats. Cancer Res. 52: 5037-5041, 1992.
35. Squartini, F., and Pingitore, R. Tumours of the mammary gland. In: V. S. Turusov and U. Mohr (eds.), Pathology of Tumours in Laboratory Animals, Ed. 2, pp. 47-100, IARC Scientific Publ. No. 111, Lyon, France: IARC, 1994.
36. Clair, T., Miller, W. R., and Cho-Chung, Y. S. Prognostic significance of the expression of a Ras protein with molecular weight of 21,000 by human breast cancer. Cancer Res., 47: 5290-5293, 1987.
37. Hand, P. H., Vilasi, V., Thor, A., Ohuchi, N., and Schlom, J. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. J. Natl. Cancer Inst., 79: 59-65, 1987.
38. Going, J. I., Anderson, T. J., and Wyllie, A. H. Ras p21 in breast tissue: associations with pathology and cellular localisation. Br. J. Cancer, 65: 45-50, 1992.
39. Querzoli, P., Marchetti, E., Bagni, A., Marzola, A., Fabris, G., and Nenci, I. Expression of p21 ras gene products in breast cancer relates to histological types and to receptor and nodal status. Breast Cancer Res. Treat., 12: 23-30, 1988.
40. Hancock, J. F., Magee, A. I., Childs, J. E., and Marshall, C. J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57: 1167-1177, 1989.